adenosine monophosphate has been researched along with Zika Virus Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Bilello, JP; Chan, J; Chia, JJ; Cihlar, T; Cowfer, D; Feng, JY; Gong, R; Iversen, P; Kaptein, SJF; Leventhal, SM; Lu, X; Neyts, J; Porter, DP; Radoshitzky, SR; Sapre, AA; Shi, PY; Shornikov, A; Song, ZJ; Steffens, J; Stuthman, KS; Truong, H; Van Tongeren, SA; Warren, T; Wells, J; Xie, X; Yang, H; Yu, H; Zhang, X; Zou, J | 1 |
Aliota, MT; Bonnac, LF; Geraghty, RJ | 1 |
1 review(s) available for adenosine monophosphate and Zika Virus Infection
Article | Year |
---|---|
Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.
Topics: Adenosine Monophosphate; Alanine; Amides; Animals; Antiviral Agents; COVID-19 Drug Treatment; Hemorrhagic Fever, Ebola; Humans; Middle East Respiratory Syndrome Coronavirus; Mutagenesis; Nucleosides; Pyrazines; Ribavirin; SARS-CoV-2; Virus Replication; Zika Virus; Zika Virus Infection | 2021 |
2 other study(ies) available for adenosine monophosphate and Zika Virus Infection
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Filoviridae; Hemorrhagic Fever, Ebola; Humans; Zika Virus; Zika Virus Infection | 2023 |